IL143280A0 - Use of riluzole for treating acoustic traumas - Google Patents

Use of riluzole for treating acoustic traumas

Info

Publication number
IL143280A0
IL143280A0 IL14328099A IL14328099A IL143280A0 IL 143280 A0 IL143280 A0 IL 143280A0 IL 14328099 A IL14328099 A IL 14328099A IL 14328099 A IL14328099 A IL 14328099A IL 143280 A0 IL143280 A0 IL 143280A0
Authority
IL
Israel
Prior art keywords
riluzole
treating acoustic
traumas
acoustic traumas
treating
Prior art date
Application number
IL14328099A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL143280A0 publication Critical patent/IL143280A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
IL14328099A 1998-12-15 1999-12-13 Use of riluzole for treating acoustic traumas IL143280A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9815834A FR2787028B1 (fr) 1998-12-15 1998-12-15 Utilisation du riluzole dans le traitement des traumatismes acoustiques
PCT/FR1999/003108 WO2000035447A1 (fr) 1998-12-15 1999-12-13 Utilisation du riluzole dans le traitement des traumatismes acoustiques

Publications (1)

Publication Number Publication Date
IL143280A0 true IL143280A0 (en) 2002-04-21

Family

ID=9533998

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14328099A IL143280A0 (en) 1998-12-15 1999-12-13 Use of riluzole for treating acoustic traumas
IL143280A IL143280A (en) 1998-12-15 2001-05-21 Use of Rilozol in the preparation of drugs for the prevention and / or treatment of acoustic traumas

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143280A IL143280A (en) 1998-12-15 2001-05-21 Use of Rilozol in the preparation of drugs for the prevention and / or treatment of acoustic traumas

Country Status (20)

Country Link
US (1) US6660757B2 (de)
EP (1) EP1140080B1 (de)
JP (2) JP4831866B2 (de)
KR (1) KR100641473B1 (de)
AT (1) ATE278401T1 (de)
AU (1) AU773639B2 (de)
BR (1) BR9916244A (de)
CA (1) CA2355359C (de)
CZ (1) CZ292078B6 (de)
DE (1) DE69920959T2 (de)
ES (1) ES2229796T3 (de)
FR (1) FR2787028B1 (de)
HU (1) HU228889B1 (de)
IL (2) IL143280A0 (de)
NO (1) NO326764B1 (de)
PT (1) PT1140080E (de)
SK (1) SK285206B6 (de)
UA (1) UA72229C2 (de)
WO (1) WO2000035447A1 (de)
ZA (1) ZA200104827B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787028B1 (fr) * 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques
AU2007313412A1 (en) 2006-10-13 2008-04-24 The University Of North Carolina At Chapel Hill Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea
TW201039383A (en) * 2009-04-17 2010-11-01 Arima Optoelectronics Corp Semiconductor chip electrode structure and manufacturing method thereof
CN107735077A (zh) * 2014-11-21 2018-02-23 拜尔哈文制药股份有限公司 利鲁唑的舌下给药
WO2016081472A1 (en) * 2014-11-21 2016-05-26 Biohaven Pharmaceutical Holding Company Ltd. Sublingual formulation of riluzole
JP6999896B2 (ja) 2017-09-21 2022-01-19 学校法人慶應義塾 音響外傷難聴モデル動物の作製方法及びそれにより作製される音響外傷難聴モデル動物
WO2025133679A1 (en) * 2023-12-18 2025-06-26 Associação Para Desenvolvimento Do Centro Académico De Investigação E Formação Biomédica Do Algarve, Ad-Abc Compounds and composition for dna protection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US4826860A (en) 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
FR2619713B1 (fr) 1987-08-25 1990-08-31 Rhone Poulenc Sante Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
FR2619712B1 (fr) 1987-08-25 1990-08-31 Rhone Poulenc Sante Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la schizophrenie
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2700117B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2700116B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants comme radioprotecteurs.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents
ES2168119T3 (es) * 1995-10-10 2002-06-01 Pfizer Derivados de quinoxalina para el tratamiento de tinnitus.
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
FR2787028B1 (fr) * 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques

Also Published As

Publication number Publication date
US6660757B2 (en) 2003-12-09
ATE278401T1 (de) 2004-10-15
CZ20012085A3 (cs) 2001-09-12
PT1140080E (pt) 2005-01-31
JP2002532424A (ja) 2002-10-02
AU773639B2 (en) 2004-05-27
EP1140080B1 (de) 2004-10-06
NO20012777L (no) 2001-06-06
SK285206B6 (sk) 2006-08-03
CZ292078B6 (cs) 2003-07-16
KR100641473B1 (ko) 2006-10-31
FR2787028A1 (fr) 2000-06-16
HUP0104698A3 (en) 2004-05-28
WO2000035447A1 (fr) 2000-06-22
NO20012777D0 (no) 2001-06-06
BR9916244A (pt) 2001-10-02
ES2229796T3 (es) 2005-04-16
NO326764B1 (no) 2009-02-09
CA2355359A1 (fr) 2000-06-22
FR2787028B1 (fr) 2002-10-18
HUP0104698A2 (hu) 2002-04-29
SK8242001A3 (en) 2001-12-03
KR20010101192A (ko) 2001-11-14
EP1140080A1 (de) 2001-10-10
DE69920959T2 (de) 2005-09-01
UA72229C2 (en) 2005-02-15
JP4831866B2 (ja) 2011-12-07
JP2011219497A (ja) 2011-11-04
CA2355359C (fr) 2009-02-03
HU228889B1 (en) 2013-06-28
JP5536722B2 (ja) 2014-07-02
IL143280A (en) 2007-10-31
DE69920959D1 (de) 2004-11-11
US20020004516A1 (en) 2002-01-10
AU1569600A (en) 2000-07-03
ZA200104827B (en) 2002-09-13

Similar Documents

Publication Publication Date Title
BG105830A (en) C-21 modified epothilones
WO2000038786A3 (en) Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
DE60123276D1 (de) Piperazinderivate zur behandlung bakterieller infektionen
SG144712A1 (en) Nordihydroguaiartic derivaties for use in treatment of tumors
NZ509729A (en) Agents with an antidepressive effect
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
TR199900505T2 (de)
GB9804886D0 (en) Therapeutic combination
ZA200201819B (en) Preventive and therapeutic agents for eye diseases.
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU1556497A (en) Agents for the treatment and prevention of aids
EP0681787A3 (de) Verwendung eines Enzyms zur Herstellung eines Mittels für die Behandlung und/oder Prophylaxe von Coccidiose.
IL143280A0 (en) Use of riluzole for treating acoustic traumas
EE05211B1 (et) Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
IL130968A0 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
WO2001041769A3 (fr) Association de cyamemazine et d'un neuroleptique atypique
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner
EP1083914A4 (de) Behandlung der arthritis und anderer ähnlicher störungen
AU2177401A (en) Combination of riluzole and gabapentin and use thereof as medicine
WO2000027376A3 (de) Verwendung von thiolverbindungen, oxidoreduktasen und/oder hydrolasen zur behandlung des tinnitus, insbesondere des chronischen tinnitus
AU4834601A (en) Use of cdp-choline for the prophylactic treatment of cerebral ischemia
IL152989A0 (en) Use of riluzole or its salts for preventing and treating ?noleukodystrophy
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
BG100479U (en) Medicament for the local treatment of otitis

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed